Skip to content

Clinical trials

Wet Macular Degeneration trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wet Macular Degeneration Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20161
20181
20192
20202
20211
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Bayer2
Centre Hospitalier Intercommunal Creteil2
4D Molecular Therapeutics1
AbbVie1
Adverum Biotechnologies, Inc.1
EyeBiotech Ltd.1
Hoffmann-La Roche1
Opthea Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wet Macular Degeneration13
Macular Degeneration9
Choroidal Neovascularization6
Eye Diseases5
Retinal Degeneration4
Retinal Diseases4
Vision Disorders4
Geographic Atrophy3
Blindness2
Retinal Vein Occlusion1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.